|
DYN Dyne Therapeutics Inc 1818794 |
| Balance Sheet |
|
Current Assets
|
659,279,000 |
|
Assets
|
691,234,000 |
|
Current Liabilities
|
42,258,000 |
|
Liabilities
|
61,396,000 |
|
Equity
|
629,838,000 |
|
Shares Out
|
100,401,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-292,369,000 |
|
Investing Cash Flow
|
-204,076,000 |
| Market Analysis |
Market Cap
|
3,501,976,523 |
|
Price
|
12.31 |
|
BVPS
|
6.27 |
|
PB
|
1.99 |
|
EPS
|
-3.58 |
|
PS
|
0.87 |
|
FCF
|
-496,445,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/27 |
-3.37 |
3/05 |
0.42 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DYN documents filed with the SEC.
DYN Filings
Clear
